T1	Participants 2 47	clinical trial of glutathione supplementation
T2	Participants 545 627	trial using oral lipoceutical glutathione (n=13) or transdermal glutathione (n=13)
T3	Participants 755 882	plasma reduced glutathione, oxidized glutathione, cysteine, taurine, free and total sulfate, and whole-blood glutathione levels
T4	Participants 1257 1348	supplementation may have some benefit in improving some of the transsulfuration metabolites
T5	Participants 1449 1565	glutathione supplementation and evaluate the potential effects of glutathione supplementation upon clinical symptoms
